Systematic evolution of ligands by exponential enrichment

SELEX_schematic.png

Systematic evolution of ligands by exponential enrichment (SELEX) is an in vitro selection technique used to identify nucleic acid ligands, known as aptamers, that have a high affinity for specific target molecules. This method is widely used in molecular biology, biochemistry, and biotechnology for the development of diagnostic and therapeutic agents.

History

The SELEX process was independently developed by two research groups in 1990. The technique has since become a fundamental tool in the field of molecular evolution and has been adapted for various applications, including the development of biosensors, drug delivery systems, and targeted therapies.

Process

The SELEX process involves several iterative steps:

1. **Library Preparation**: A large library of random oligonucleotides is synthesized. These oligonucleotides can be composed of DNA, RNA, or modified nucleic acids.
2. **Binding**: The library is incubated with the target molecule, allowing potential aptamers to bind to the target.
3. **Partitioning**: Bound oligonucleotides are separated from unbound ones. This can be achieved through various methods such as affinity chromatography, filtration, or magnetic separation.
4. **Amplification**: The bound oligonucleotides are amplified using polymerase chain reaction (PCR) for DNA or reverse transcription followed by PCR for RNA.
5. **Iteration**: The amplified oligonucleotides are subjected to additional rounds of binding, partitioning, and amplification to enrich the pool for high-affinity aptamers.

Applications

SELEX has numerous applications in both research and clinical settings:

• **Diagnostics**: Aptamers selected through SELEX can be used in biosensors for the detection of various biomarkers.
• **Therapeutics**: Aptamers can be developed as therapeutic agents to target specific proteins or cells in diseases such as cancer and viral infections.
• **Research Tools**: Aptamers can be used to study protein-protein interactions, cell signaling pathways, and other biological processes.

Advantages

SELEX offers several advantages over traditional methods of ligand discovery:

• **Specificity**: Aptamers can be selected to bind with high specificity to their target molecules.
• **Versatility**: The SELEX process can be adapted to select aptamers for a wide range of targets, including small molecules, proteins, and even whole cells.
• **Stability**: Aptamers are generally more stable than antibodies and can be easily modified to enhance their properties.

Limitations

Despite its advantages, SELEX also has some limitations:

• **Complexity**: The SELEX process can be time-consuming and requires specialized equipment and expertise.
• **Cost**: The synthesis and amplification of large oligonucleotide libraries can be expensive.
• **Target Accessibility**: Some targets may be difficult to access or present in low abundance, complicating the selection process.

See also

• Aptamer
• In vitro selection
• Molecular evolution
• Polymerase chain reaction
• Affinity chromatography

References

‎